Source: Annual Congress 2004 - Targeting acute and chronic airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. O‘Donnell, K. F. Rabe, C. Jenkins, J. F. Muir, S. Witte, D. Bredenbroeker (Kingston, Canada; Leiden, The Netherlands; Camperdown, Australia; Rouen, France; Konstanz, Germany). FEV₆: a useful outcome measure of lung function in COPD as assessed in a large clinical study with roflumilast. Eur Respir J 2004; 24: Suppl. 48, 2151

Member's Comments

No comment yet.

Related content which might interest you: Which lung function variables are the most sensitive to a short bronchodilator in COPD patients? Source: Annual Congress 2008 - Quality spirometry: the only spirometry! Year: 2008 Clinically meaningful improvements with reslizumab in patient-reported outcomes and lung function in a sub-population defined by the EU indication with =3 exacerbations Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 The usefulness of a combination with patient-based questionnaire and lung function test for predicting asthma exacerbation Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Outcomes for COPD pharmacological trials: from lung function to biomarkers Source: Eur Respir J 2008; 31: 416-469 Year: 2008 What is the best method for investigating the impact of tiotropium on hyperinflation in COPD? Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Clinical relevance of small airways assessment by lung function tests in asthma Source: International Congress 2018 – Biomarkers and lung function in airway disease Year: 2018 Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases Year: 2015 Lung function values as predictors for outcome during non-invasive ventilation in COPD patients Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011 ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials Source: Virtual Congress 2021 – Future advances in respiratory physiology Year: 2021 A retrospective evaluation of lung function and exacerbations in COPD patients-RETRIEVE study. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Formoterol and tiotropium both improve lung function in stable COPD patients, with some additional benefit when given together Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006 Prediction of lung emphysema in COPD by spirometry and clinical symptoms: results from COSYCONET Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021 An airway challenge test can predict COPD: an international cohort study Source: International Congress 2017 – COPD: risk factors and prognosis Year: 2017 Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015 Double blind, placebo controlled crossover study in COPD patients to assess the acute effect of budesonide/formoterol using HRCT and lung function tests Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 A new class of bronchodilator improves lung function in COPD: a trial with GSK961081 Source: Eur Respir J 2013; 42: 972-981 Year: 2013 Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013